PATENT CLAIM ANALYSIS

Application Number: 15767768
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "564000"]

Abstract:
Described are deuterated chlorokynurenines and compositions, and their application as pharmaceuticals for the treatment of disease. Methods of modulating N-methyl-D-aspartate (NMDA) receptor activity, methods of treating disorders, including neuropsychiatric disorders such as depression, epilepsy, schizophrenia, and Huntington's Disease, and use of said deuterated chlorokynurenines are also described.

Claim (Index 15):
The compound of  claim 8 , which is or a salt thereof.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 91.0
- Lexical Diversity: 1.43902
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12552663', '12234318', '14297249', '14718993', '11840143']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.746717108634915
- 35 USC 102 Novelty (BERT): 0.5269099527747607
- Combined Prediction Score: 0.7247363930488997
- Mean Citation Score: 249.78974
- Max Citation Score: 262.03775
- Similarity Product: 144.261677237466

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test